Speakers Bureau

Faculty willing to give educational talks in Boston and surrounding communities about prevention, brain health, warning signs for Alzheimer’s disease and opportunities for clinical trials.

Gad Asher Marshall. M.D.

Associate Medical Director of Clinical Trials, Center for Alzheimer's Research and Treatment, Brigham and Women's Hospital & Assistant Professor of Neurology, Harvard Medical School

Biography: Gad Marshall is board certified in Neurology. He is currently the Associate Medical Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Assistant Professor of Neurology at Harvard Medical School. Dr. Marshall has been site principal investigator for multiple clinical trials of amyloid-modifying drugs in Alzheimer’s disease and is currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 2, DoD-ADNI, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. His research has focused on clinical correlates of activities of daily living and neuropsychiatric symptoms with PiB and FDG PET, structural and resting-state functional MRI, and CSF biomarkers across the early Alzheimer’s disease spectrum.

Scott McGinnis, M.D.

Assistant Professor of Neurology at Harvard Medical School and a behavioral neurologist at the BWH Center for Brain Mind Medicine.

Biography: Scott McGinnis is Assistant Professor of Neurology at Harvard Medical School and a behavioral neurologist at the BWH Center for Brain Mind Medicine. He completed his residency in neurology in the Partners program and a fellowship in cognitive and behavioral neurology at BWH. Dr McGinnis’ career comprises patient care, education of students, residents, and fellows, and work on clinical research studies in aging and neurodegenerative dementias. His research interests include frontotemporal dementia, atypical presentations of Alzheimer disease and additional non-Alzheimer neurodegenerative dementias. He is an investigator in the Center for Alzheimer Research and Treatment at BWH and at the MGH Frontotemporal Disorders Unit. He has clinical expertise in the evaluation and management of patients with cognitive impairment and dementia. 

Kathryn V. Papp, Ph.D.

Neuropsychologist, Brigham and Women's Hospital Instructor, Harvard Medical School

Biography: Kathryn Papp, PhD is a clinical neuropsychologist with a primary interest in the early detection of Alzheimer’s disease (AD).  Her research focuses on the development of sensitive semantic and associative memory tests designed to identify individuals who may be at risk for AD progression. She is additionally interested in modifiable lifestyle factors which may mitigate cognitive decline in older adults.

Yakeel T. Quiroz, Ph.D.

Instructor in Psychology (Psychiatry), Harvard Medical School

Additional Languages Spoken: Spanish

Biography: Yakeel T. Quiroz is a neuropsychologist and clinical researcher at Massachusetts General Hospital/Harvard Medical School. She completed her Ph.D. training in clinical psychology at Boston University and a postdoctoral fellowship at MGH. With an NIH Director’s Early Independence Award, Dr. Quiroz recently launched her own lab where she seeks to identify and validate biomarkers for early detection of Alzheimer’s disease. She also co-directs the Multicultural Neuropsychology Program at MGH (http://www.massgeneral.org/psychiatry/services/mundos_home.aspx), a service that offers culturally appropriate bilingual neuropsychological testing and interventions to Latino children and adults.

Dorene M. Rentz, PsyD

Associate Professor of Neurology Harvard Medical School, Departments of Neurology at Brigham and Women's Hospital and Massachusetts General Hospital

Biography: Dorene M. Rentz, PsyD, is an Associate Professor of Neurology at Harvard Medical School with dual appointments in the Departments of Neurology at Brigham and Women’s Hospital and Massachusetts General Hospital, Boston, Massachusetts. She completed her degree in clinical psychology/ neuropsychology in 1987 and has worked as a clinical neuropsychologist for 29 years.  She serves in multiple capacities as the Co-Director of the Center for Alzheimer Research and Treatment; the Director of Neuropsychology of the Massachusetts Alzheimer’s Disease Research Center (MADRC); Co-Leader of the Outreach, Recruitment and Education Core and Clinical Core Leader of the Harvard Aging Brain Study. Her research interests include early detection of cognitive and behavioral changes in preclinical Alzheimer’s disease using novel cognitive assessments as well as amyloid and tau PET imaging.  On an international level, Dorene is involved in designing cognitive outcome measures for secondary prevention trials in AD and is a proponent of validating at-home computerized assessments. 

Jeffrey M. Robbins, LICSW

Clinical Social Worker, Brigham and Women's Hospital, Teaching Associate, Harvard Medical School

Biography: Jeffrey Robbins is a licensed clinical social worker in Neurology at Brigham and Women’s Hospital and a Teaching Associate in Neurology at Harvard Medical School. Jeff has spent the last 35 years counseling individuals and families living with Alzheimer’s disease and he has given multiple presentations on issues pertaining to caregivers. In 1998 he co-founded The Eleanor Robbins Community Program: Caring for Each Other; a Volunteer program for students wanting to learn about Alzheimer’s disease through weekly visits with a nursing home resident on a dementia care unit. This program became the template for a non- profit, National Alzheimer’s Buddies (NAB), an initiative involving college students who visit those living with Alzheimer’s. NAB currently has 10 colleges across the country who are participating in this program.

Hyun-Sik Yang, M.D.

Behavioral Neurology Fellow, Brigham and Women's Hospital and Clinical Fellow in Neurology, Harvard Medical School

Biography: Dr. Hyun-Sik Yang is a behavioral neurology fellow at Brigham and Women's Hospital, and a clinical Alzheimer disease research fellow at Center for Alzheimer Research and Treatment (CART) at Brigham and Women's Hospital. He is also a clinical fellow in neurology at Harvard Medical School. Dr. Yang sees patients with dementia or other cognitive problems, and his research focuses on disease modifiers of Alzheimer's disease such as genetic variations, coexisting pathologies, and medical comorbidities. Dr. Yang is also a sub-investigator for various Alzheimer's disease clinical trials at CART.

Dr. Yang graduated from Seoul National University College of Medicine, and finished his residency at Harvard Neurology Residency Program at Brigham and Women's Hospital and Massachusetts General Hospital. Dr. Yang is a recipient of American Academy Academy of Neurology's 2016 Annual Meeting Resident Research Travel Scholarship, and 2017 Alzheimer's Association Clinical Fellowship Award.

Yi Zhou, M.D.

Visiting Observer at Massachusetts Alzheimer's Disease Research Center and Memory Disorders Unit at the Massachusetts General Hospital

Additional Languages Spoken: Chinese (Mandarin)

Biography: Dr. Yi Zhou is a visiting observer at Massachusetts Alzheimer's Disease Research Center and Memory Disorders Unit at the Massachusetts General Hospital. She received her M.D. from Shanghai Jiao Tong University School of Medicine and was trained in the Department of Neurology at Shanghai Rui Jin Hospital. She is pursuing graduate studies in public health at Harvard T.H. Chan School of Public Health.

Pages